Cellavita Scientific Research

Cellavita is a Brazilian biotechnology company dedicated to the development of advanced cell therapies and regenerative medicine. The company primarily focuses on utilizing mesenchymal stem cells (MSCs) to treat neurodegenerative diseases, with a lead clinical program targeting Amyotrophic Lateral Sclerosis (ALS). Cellavita maintains specialized laboratory infrastructure for the isolation, characterization, and large-scale expansion of stem cells under rigorous quality standards. Their research efforts are supported by collaborations with leading Brazilian medical institutions and regulatory alignment with ANVISA. The company's mission is to translate stem cell research into accessible therapeutic solutions for patients with high unmet medical needs.